Published in Korean J Intern Med on July 01, 1987
Immunofluorescent studies of the development of pre-B cells, B lymphocytes and immunoglobulin isotype diversity in humans. Eur J Immunol (1977) 4.00
Factors affecting B-cell growth and differentiation. Annu Rev Immunol (1985) 2.78
On the varied biologic effects of interferon. Cell Immunol (1977) 2.47
Inhibition of the primary in vitro antibody response by interferon preparations. J Immunol (1975) 2.35
Gamma-interferon is one of several direct B cell-maturing lymphokines. Nature (1984) 2.18
Antitumor effects of interferon. Biochim Biophys Acta (1978) 2.04
Proliferative responses of normal human B lymphocytes. Development of an assay system for human B cell growth factor (BCGF). J Immunol (1982) 2.02
Effect of recombinant IL 2 and gamma-IFN on proliferation and differentiation of human B cells. J Immunol (1985) 1.92
Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma. Ann Intern Med (1980) 1.91
Polyclonal B-cell activators in the study of the regulation of immunoglobulin synthesis in the human system. Adv Immunol (1982) 1.85
Effects of interferon on antibody synthesis in vitro. J Immunol (1974) 1.73
Defective B-lymphocyte function in homosexual men in relation to the acquired immunodeficiency syndrome. Ann Intern Med (1984) 1.63
Simplified procedure for the separation of human T and non-T cells. Vox Sang (1977) 1.49
Polyclonal immunoglobulin secretion by human B lymphocytes exposed to Epstein-Barr virus in vitro. J Immunol (1979) 1.46
Time and dosage dependence of immunoenhancement by murine type II interferon preparations. Cell Immunol (1978) 1.43
The use of the enzyme-linked immunosorbent assay (ELISA) for the detection and quantification of specific antibody from cell cultures. Immunology (1979) 1.43
Characteristics of Epstein-Barr virus activation of human B lymphocytes. J Exp Med (1981) 1.43
Interferon and spontaneous cytotoxicity in man. I. Enhancement of the spontaneous cytotoxicity of peripheral lymphocytes by human leukocyte interferon. Int J Cancer (1978) 1.33
Disorders of B cells and helper T cells in the pathogenesis of the immunoglobulin deficiency of patients with ataxia telangiectasia. J Clin Invest (1983) 1.21
Enhancement of human natural cell-mediated cytotoxicity by interferon. Br J Cancer (1980) 1.11
Enhancement of T cell cytotoxic responses by purified human fibroblast interferon. J Immunol (1978) 1.05
Spontaneous plaque forming cells in the peripheral blood of patients with systemic lupus erythematosus. Clin Exp Immunol (1982) 0.98
Activation, proliferation, and differentiation of circulating B cells in autoimmune thyroid disease. J Immunol (1985) 0.87
Effect of interferon alpha on pokeweed mitogen-induced differentiation of human peripheral blood b lymphocytes. Cell Immunol (1981) 0.86
Immunoregulatory effects of interferon-alpha. I. Interferon-alpha inhibits in vitro antibody synthesis by normal human lymphocytes. Clin Exp Immunol (1985) 0.82
Cellular events in the differentiation of antibody-secreting cells. Semin Hematol (1984) 0.79
RXR beta: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell (1991) 5.89
ABFs, a family of ABA-responsive element binding factors. J Biol Chem (2000) 4.98
Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy. Proc Natl Acad Sci U S A (2009) 4.58
alpha-Synuclein gene duplication is present in sporadic Parkinson disease. Neurology (2007) 3.62
Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J (1999) 3.50
Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group. Blood (1994) 2.78
Long-term metformin use reduces gastric cancer risk in type 2 diabetics without insulin treatment: a nationwide cohort study. Aliment Pharmacol Ther (2014) 2.66
The prediction of abdominal visceral fat level from body composition and anthropometry: ROC analysis. Int J Obes Relat Metab Disord (1999) 2.41
Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. N Engl J Med (1991) 2.40
Antineutrophil cytoplasmic autoantibody associated vasculitis and renal failure in Behçet disease. Nephrol Dial Transplant (1993) 2.33
Congenital dyserythropoietic anemia with karyorrhexis and multinuclearity of erythroblasts. Helv Med Acta (1968) 2.02
Second-line chemotherapy versus supportive cancer treatment in advanced gastric cancer: a meta-analysis. Ann Oncol (2013) 2.02
Lipopolysaccharide induces hyporesponsiveness to its own action in RAW 264.7 cells. J Biol Chem (1989) 2.00
Is obesity still increasing among pregnant women? Prepregnancy obesity trends in 20 states, 2003-2009. Prev Med (2013) 1.97
Pre-hospital notification reduced the door-to-needle time for iv t-PA in acute ischaemic stroke. Eur J Neurol (2009) 1.97
Mutations in the rpoB gene of Mycobacterium tuberculosis that interfere with PCR-single-strand conformation polymorphism analysis for rifampin susceptibility testing. J Clin Microbiol (1997) 1.89
Changing trends in clinical manifestations of laryngeal tuberculosis. Laryngoscope (2000) 1.88
Biliary papillomatosis: clinical, cholangiographic and cholangioscopic findings. Endoscopy (1998) 1.85
Maternal obesity and risk of cesarean delivery: a meta-analysis. Obes Rev (2007) 1.85
Specific DWI lesion patterns predict prognosis after acute ischaemic stroke within the MCA territory. J Neurol Neurosurg Psychiatry (2005) 1.81
Analysis of long terminal repeat circle junctions of human immunodeficiency virus type 1. J Virol (1990) 1.80
Aetiology and clinical significance of thrombocytosis: analysis of 732 patients with an elevated platelet count. J Intern Med (1999) 1.79
Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas. Cancer Res (1999) 1.74
Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis (1999) 1.63
Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings. N Engl J Med (1992) 1.59
Electric modulation of conduction in multiferroic Ca-doped BiFeO3 films. Nat Mater (2009) 1.59
Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer. Oncogene (1999) 1.59
The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation. Bone (2002) 1.57
High-level tuber expression and sucrose inducibility of a potato Sus4 sucrose synthase gene require 5' and 3' flanking sequences and the leader intron. Plant Cell (1995) 1.56
Teaching NeuroImage: Wall-eyed bilateral internuclear ophthalmoplegia (WEBINO) from midbrain infarction. Neurology (2008) 1.55
Frequent somatic mutations in serine/threonine kinase 11/Peutz-Jeghers syndrome gene in left-sided colon cancer. Cancer Res (1998) 1.55
Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia (2012) 1.55
Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationships. Biochem Pharmacol (1999) 1.55
Impregnation of vancomycin, gentamicin, and cefotaxime in a cement spacer for two-stage cementless reconstruction in infected total hip arthroplasty. J Arthroplasty (2001) 1.51
Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia. Ann Hematol (1994) 1.51
Cross-cultural adaptation and validation of Korean Western Ontario and McMaster Universities (WOMAC) and Lequesne osteoarthritis indices for clinical research. Osteoarthritis Cartilage (2001) 1.49
Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer. Cancer Res (1999) 1.47
Clinical and angiographic follow-up of stent-only therapy for acute intracranial vertebrobasilar dissecting aneurysms. AJNR Am J Neuroradiol (2009) 1.47
Extensive partial unilateral lentiginosis. J Eur Acad Dermatol Venereol (2006) 1.46
Coexistence of ankylosing spondylitis and mixed connective tissue disease in a single patient. Clin Exp Rheumatol (1999) 1.46
Preoperative detection and predictors of level V lymph node metastasis in patients with papillary thyroid carcinoma. Br J Surg (2012) 1.45
Substrate recognition by the ClpA chaperone component of ClpAP protease. J Biol Chem (2000) 1.45
The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC. Oncogene (2008) 1.45
[Severe tetraparesis as the first manifestation of a chronic lymphatic leukemia]. Dtsch Med Wochenschr (1992) 1.39
[Fall Congress for Integrative Medicine--model for the future]. Dtsch Med Wochenschr (2009) 1.38
Superoxide modulates the oxidation and nitrosation of thiols by nitric oxide-derived reactive intermediates. Chemical aspects involved in the balance between oxidative and nitrosative stress. J Biol Chem (1997) 1.37
A potato Sus3 sucrose synthase gene contains a context-dependent 3' element and a leader intron with both positive and negative tissue-specific effects. Plant Cell (1995) 1.35
The JAK2 V617F mutation in de novo acute myelogenous leukemias. Oncogene (2006) 1.34
Skene's duct cysts in female newborns. J Pediatr Surg (1992) 1.33
Fluorous synthesis: a fluorous-phase strategy for improving separation efficiency in organic synthesis. Science (1997) 1.33
Identification of lipopolysaccharide-binding proteins in 70Z/3 cells by photoaffinity cross-linking. J Biol Chem (1990) 1.33
Mutations of tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) and receptor 2 (TRAIL-R2) genes in metastatic breast cancers. Cancer Res (2001) 1.31
Congenital dyserythropoietic anaemia, types I and II: aberrant pattern of erythrocyte membrane proteins in CDA II, as revealed by two-dimensional polyacrylamide gel electrophoresis. Br J Haematol (1977) 1.30
A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes. Leukemia (2004) 1.28
Expression of Fas and Fas-related molecules in human hepatocellular carcinoma. Hum Pathol (2001) 1.27
Multiple cis-active elements in the long control region of bovine papillomavirus type 1 (BPV-1). Nucleic Acids Res (1987) 1.27
Shorter duration of oral N-acetylcysteine therapy for acute acetaminophen overdose. Ann Emerg Med (2000) 1.25
Convenient colorimetric and fluorometric assays for S-nitrosothiols. Anal Biochem (1996) 1.25
MR imaging findings of paravertebral gossypiboma. AJNR Am J Neuroradiol (2007) 1.22
Mesenchymal progenitor cells in the human umbilical cord. Ann Hematol (2004) 1.22
Somatic mutations of Fas (Apo-1/CD95) gene in cutaneous squamous cell carcinoma arising from a burn scar. J Invest Dermatol (2000) 1.21
High levels of thrombopoietin in sera of patients with essential thrombocythemia: cause or consequence of abnormal platelet production? Ann Hematol (1998) 1.21
Somatic mutations of the trefoil factor family 1 gene in gastric cancer. Gastroenterology (2000) 1.21
Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation. Cochrane Database Syst Rev (2007) 1.20
Direct identification of Vibrio vulnificus in clinical specimens by nested PCR. J Clin Microbiol (1998) 1.18
Stress increases brain-derived neurotropic factor messenger ribonucleic acid in the hypothalamus and pituitary. Endocrinology (1995) 1.17
Clonorchiasis: sonographic findings in 59 proved cases. AJR Am J Roentgenol (1989) 1.17
Reliability and validity of systemic lupus activity measure-revised (SLAM-R) for measuring clinical disease activity in systemic lupus erythematosus. Lupus (2001) 1.17
Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group. Blood (1993) 1.16
A prospective study on the added value of pulsed arterial spin-labeling and apparent diffusion coefficients in the grading of gliomas. AJNR Am J Neuroradiol (2007) 1.16
Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia. Blood (1989) 1.14
Electron and light microscopic study of the erythroblasts of patients with congenital dyserythropoietic anemia. Blood (1971) 1.14
Observation of reactor electron antineutrinos disappearance in the RENO experiment. Phys Rev Lett (2012) 1.14
BRAF mutations in non-Hodgkin's lymphoma. Br J Cancer (2003) 1.13
Maternal deprivation and stress induce immediate early genes in the infant rat brain. Endocrinology (1997) 1.12
Alterations of the DR5/TRAIL receptor 2 gene in non-small cell lung cancers. Cancer Res (1999) 1.12
Induction of arthritis in monkeys by immunization with type II collagen. J Exp Med (1988) 1.12
Vibrio vulnificus has the transmembrane transcription activator ToxRS stimulating the expression of the hemolysin gene vvhA. J Bacteriol (2000) 1.12
A simple, precise and economical microdissection technique for analysis of genomic DNA from archival tissue sections. Virchows Arch (1998) 1.12
Ion channel expression in PMA-differentiated human THP-1 macrophages. J Membr Biol (1996) 1.12
Identification of high-risk patients with aplastic anaemia in selection for allogeneic 0one-marrow transplantation. Lancet (1976) 1.10
Life-threatening common carotid artery blowout: rescue treatment with a newly designed self-expanding covered nitinol stent. Br J Radiol (2006) 1.09
Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrin. Oncogene (2009) 1.09
Emergence of CD52-, phosphatidylinositolglycan-anchor-deficient T lymphocytes after in vivo application of Campath-1H for refractory B-cell non-Hodgkin lymphoma. Blood (1995) 1.09
Sestamibi parathyroid imaging. Semin Nucl Med (1995) 1.09
Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis. Aliment Pharmacol Ther (2009) 1.08
Comparison of inferior oblique muscle weakening by anterior transposition or myectomy: a prospective study of 20 cases. Br J Ophthalmol (1999) 1.08
Structure and organization of the human transglutaminase 1 gene. J Biol Chem (1992) 1.07
Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted imaging in patients with gliomas: comparison with MR perfusion imaging. AJNR Am J Neuroradiol (2009) 1.07
Colorectal cancer pulmonary oligometastases: pooled analysis and construction of a clinical lung metastasectomy prognostic model. Ann Oncol (2012) 1.07
Nonenhancing intramedullary astrocytomas and other MR imaging features: a retrospective study and systematic review. AJNR Am J Neuroradiol (2009) 1.06
Tuberculous aneurysm of the abdominal aorta: endovascular repair using stent grafts in two cases. Korean J Radiol (2001) 1.06
Optimal size matching in single lung transplantation. J Heart Lung Transplant (1995) 1.06
In vivo/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMT. Bone Marrow Transplant (1995) 1.06
Alterations of Fas (APO-1/CD95) gene in transitional cell carcinomas of urinary bladder. Cancer Res (1999) 1.06
Psychometric evaluation of a Korean Health Assessment Questionnaire for clinical research. J Rheumatol (1998) 1.06
Ramosetron for the prevention of cisplatin-induced acute emesis: a prospective randomized comparison with granisetron. J Int Med Res (2002) 1.05